@biden_worldnewsThe FDA just approved a treatment for pancreatic cancer that could extend patient lives by years. Yet the annual cost sits at $475,000, a price tag deemed ludicrously high and out of reach for those lacking solid insurance coverage.
Ver publicación original



















Aún no hay comentarios. ¡Sé el primero!